<SEC-DOCUMENT>0001121404-23-000002-index.html : 20230203 <SEC-HEADER>0001121404-23-000002.hdr.sgml : 20230203 <ACCEPTANCE-DATETIME>20230203114039 ACCESSION NUMBER: 0001121404-23-000002 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 6 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230203 DATE AS OF CHANGE: 20230203 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sanofi CENTRAL INDEX KEY: 0001121404 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133529324 STATE OF INCORPORATION: I0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-31368 FILM NUMBER: 23584471 BUSINESS ADDRESS: STREET 1: 46 AVENUE DE LA GRANDE ARMEE CITY: PARIS STATE: I0 ZIP: 75017 BUSINESS PHONE: 33153774400 MAIL ADDRESS: STREET 1: 46 AVENUE DE LA GRANDE ARMEE CITY: PARIS STATE: I0 ZIP: 75017 FORMER COMPANY: FORMER CONFORMED NAME: SANOFI-AVENTIS DATE OF NAME CHANGE: 20040826 FORMER COMPANY: FORMER CONFORMED NAME: SANOFI SYNTHELABO SA DATE OF NAME CHANGE: 20010104 </SEC-HEADER> <DOCUMENT> <TYPE>6-K <SEQUENCE>1 <FILENAME>a6kcoverpagepressreleaseq4.htm <DESCRIPTION>6-K <TEXT> Document 1 - file: a6kcoverpagepressreleaseq4.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>2 <FILENAME>pressreleaseq42022english.htm <DESCRIPTION>EX-99.1 <TEXT> Document 2 - file: pressreleaseq42022english.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>chart-77caa408d3724fb9a48.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 3 - file: chart-77caa408d3724fb9a48.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>chart-8f98b6910d09426f888.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 4 - file: chart-8f98b6910d09426f888.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>esgratingsq4v2.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: esgratingsq4v2.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>image.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 6 - file: image.jpg
</DOCUMENT> </SEC-DOCUMENT>